Dow R. Wilson is president and chief executive officer of Varian Medical Systems, a NYSE-listed medical device manufacturer with more than $2.6 billion in global sales. Varian designs and manufactures advanced equipment and software products for treating cancer with radiation. Mr. Wilson is also a member of the company's Board of Directors.
Since joining Varian in 2005, Mr. Wilson has held key executive positions with the company. Prior to being appointed CEO in 2012, he served as executive vice president and chief operating officer and president of Varian’s Oncology Systems business.
Mr. Wilson joined Varian following a 19-year career with General Electric in a variety of senior management positions. He served as CEO for GE Healthcare-Information Technologies, a business that included all of GE Healthcare’s IT businesses plus anesthesia, cardiac, and neonatal monitoring units. Prior to that, he was general manager for a number of GE’s imaging businesses, including the X-Ray, Nuclear Medicine, Computed Tomography (CT), and Positron Emission Tomography businesses.
Currently, Mr. Wilson also serves on the Board of Directors of Varex Imaging Corporation. From 2006 to 2015, Mr. Wilson served on the Board of Directors of Saba, a cloud-based talent management solution used by leading organizations worldwide. From 2012 to 2014, he served as lead independent director and guided Saba through a CEO transition. He also served on the Audit and Nominating Committees. In 2014, he was appointed by U.S. Secretary of Commerce Penny Pritzker to a newly established President’s Advisory Council on Doing Business in Africa. Mr. Wilson also currently serves on the Board of Directors of AdvaMed, a trade association that represents 80 percent of U.S. med tech firms.
A graduate of Brigham Young University, Mr. Wilson also holds an MBA from the Amos Tuck School of Business at Dartmouth.